tiprankstipranks
Trending News
More News >
Safety Shot (SHOT)
NASDAQ:SHOT
US Market

Safety Shot (SHOT) AI Stock Analysis

Compare
827 Followers

Top Page

SH

Safety Shot

(NASDAQ:SHOT)

37Underperform
Safety Shot's overall stock score is low, primarily due to its severe financial issues, including negative profitability and balance sheet weaknesses. Technical indicators reflect bearish market sentiment, and valuation metrics indicate high risk. However, recent corporate events, such as strategic acquisitions and product launches, provide some optimism for future growth potential.

Safety Shot (SHOT) vs. S&P 500 (SPY)

Safety Shot Business Overview & Revenue Model

Company DescriptionSafety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen. The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
How the Company Makes MoneySafety Shot generates revenue through the direct sale of its health supplement products to consumers. The company markets its products via its own e-commerce platform, as well as through partnerships with various retail distributors. Key revenue streams include online sales, retail partnerships, and potential licensing agreements for its proprietary formulas. Strategic collaborations with health and wellness influencers and partnerships with retail chains contribute significantly to its earnings by expanding its market reach and brand visibility.

Safety Shot Financial Statement Overview

Summary
Safety Shot is facing significant financial challenges, with consistent losses, negative cash flows, and declining equity. The company appears to be in a precarious financial position, heavily reliant on external financing to sustain operations. While there may be potential for recovery, the current trajectory suggests a need for strategic realignment and cost management to improve financial stability.
Income Statement
23
Negative
The company has struggled significantly with profitability, as evidenced by negative gross profit, EBIT, and net income margins over the TTM (Trailing-Twelve-Months). The revenue growth rate is volatile, with a substantial decline compared to previous years, indicating instability in revenue generation.
Balance Sheet
35
Negative
The company has a moderately leveraged balance sheet with a debt-to-equity ratio that is manageable but indicates some financial risk. Stockholders' equity has decreased over time, weakening the equity ratio. The return on equity is negative, highlighting challenges in generating returns for shareholders.
Cash Flow
28
Negative
Negative free cash flow and operating cash flow indicate liquidity issues and an inability to generate sufficient cash to cover operations. The cash flow ratios are unfavorable, showing inefficiency in converting earnings into cash flows. There is some reliance on financing activities, which poses potential risks.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
1.12M202.67K6.20M2.88M1.07M6.46K
Gross Profit
-2.55M-74.46K1.03M535.49K441.10K-11.57K
EBIT
-40.68M-12.18M-11.49M-16.77M-5.14M-920.29K
EBITDA
-40.58M-12.19M-15.29M-26.18M-6.01M-918.90K
Net Income Common Stockholders
-41.56M-15.08M-15.22M-28.10M-6.29M-925.46K
Balance SheetCash, Cash Equivalents and Short-Term Investments
103.13K5.33M4.85M14.66M4.26M531.03K
Total Assets
169.31K12.71M8.69M18.87M6.53M745.79K
Total Debt
0.002.07M2.73M861.61K1.33M350.70K
Net Debt
-103.13K-1.76M800.29K-10.89M-2.93M-180.32K
Total Liabilities
28.54K3.89M5.03M2.27M2.13M366.58K
Stockholders Equity
140.78K8.82M3.67M16.60M4.39M379.21K
Cash FlowFree Cash Flow
-25.16M-10.22M-6.41M-7.81M-2.78M-692.74K
Operating Cash Flow
-23.07M-10.11M-6.40M-7.57M-2.73M-692.74K
Investing Cash Flow
-1.44M-330.05K-2.47M-13.15M-245.99K0.00
Financing Cash Flow
21.49M12.80M-955.56K28.21M6.71M1.06M

Safety Shot Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.41
Price Trends
50DMA
0.47
Negative
100DMA
0.63
Negative
200DMA
0.84
Negative
Market Momentum
MACD
-0.03
Positive
RSI
38.04
Neutral
STOCH
17.45
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SHOT, the sentiment is Negative. The current price of 0.41 is below the 20-day moving average (MA) of 0.45, below the 50-day MA of 0.47, and below the 200-day MA of 0.84, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 38.04 is Neutral, neither overbought nor oversold. The STOCH value of 17.45 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SHOT.

Safety Shot Risk Analysis

Safety Shot disclosed 46 risk factors in its most recent earnings report. Safety Shot reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Safety Shot Peers Comparison

Overall Rating
UnderperformOutperform
Sector (48)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
PEPEP
77
Outperform
$201.05B21.0952.42%3.70%0.42%5.77%
KDKDP
76
Outperform
$45.87B32.115.77%2.68%3.62%-32.23%
76
Outperform
$55.55B38.4721.27%4.94%-4.13%
76
Outperform
$9.16B80.3312.54%2.85%-43.53%
49
Neutral
$58.98M71.20%-15.11%55.55%
48
Neutral
$6.36B1.14-49.00%2.63%17.14%1.39%
37
Underperform
$30.89M-1457.29%-67.69%-104.65%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SHOT
Safety Shot
0.41
-1.90
-82.25%
KDP
Keurig Dr Pepper
33.81
3.81
12.70%
MNST
Monster Beverage
57.08
1.43
2.57%
PEP
PepsiCo
146.61
-17.51
-10.67%
REED
Reed's
1.30
-0.27
-17.20%
CELH
Celsius Holdings
35.54
-48.26
-57.59%

Safety Shot Corporate Events

Product-Related AnnouncementsM&A TransactionsBusiness Operations and Strategy
Safety Shot Expands Distribution and Plans Spin-Off
Positive
Mar 31, 2025

Safety Shot, Inc. announced significant achievements and future plans as it concludes a transformative year. The company experienced successful launches of its Sure Shot product on Amazon and its e-commerce site, both selling out quickly, indicating high demand. Clinical trials have validated the efficacy of Sure Shot in reducing alcohol’s negative effects, bolstering the company’s market position. Safety Shot is expanding its distribution through partnerships with major retailers and plans a spin-off of its Caring Brands division to unlock shareholder value. The company is also acquiring Yerbae to diversify its product offerings and enhance distribution channels. As part of its strategy, Safety Shot is shifting its marketing focus from influencer-centric campaigns to grassroots and partner-based initiatives to improve revenue alignment.

Product-Related AnnouncementsBusiness Operations and Strategy
Safety Shot Publishes Groundbreaking Hangover Cure Study
Positive
Mar 4, 2025

On March 4, 2025, Safety Shot, Inc. announced the publication of a peer-reviewed clinical trial in the Journal of Nutrition and Dietary Supplements, demonstrating the efficacy of Safety Shot® in reducing alcohol effects and hangover symptoms. This study, the first of its kind in humans, showed significant reductions in blood and breath alcohol levels and improved hangover symptoms, positioning Safety Shot® as a potential leader in the growing hangover cure market, which is projected to expand significantly by 2032.

Business Operations and Strategy
Safety Shot Appoints CORE IR & PR for Growth
Positive
Feb 28, 2025

On February 28, 2025, Safety Shot, Inc. announced the appointment of CORE IR & PR to enhance its investor relations, shareholder communications, and public relations activities. This strategic move aims to bolster Safety Shot’s market presence and communicate its growth strategies to investors and the public, leveraging CORE IR’s expertise in healthcare and retail sectors. The collaboration is expected to support Safety Shot’s continued growth and highlight its innovative product offerings.

M&A TransactionsBusiness Operations and Strategy
Safety Shot and Yerbaé CEOs to Discuss Market Plans
Positive
Feb 24, 2025

On February 24, 2025, Safety Shot, Inc. and Yerbaé Brands Corp. announced that their CEOs will participate in a webinar to discuss their plans to disrupt the functional beverage market. This follows their January 8, 2025 announcement of a definitive arrangement agreement aimed at merging Safety Shot’s wellness solutions with Yerbaé’s plant-based energy drinks, leveraging synergies in distribution and product development to expand their market presence.

Product-Related AnnouncementsBusiness Operations and Strategy
Safety Shot Secures Major Grocery Chain Order
Positive
Feb 7, 2025

On February 7, 2025, Safety Shot, Inc. announced a substantial order for its flagship product, Sure Shot, from a major Midwestern grocery chain, marking a key milestone in its retail expansion strategy. This order highlights the growing confidence of consumers and retailers in Sure Shot and underscores Safety Shot’s efforts to secure a strong presence in the grocery sector, with plans for increased distribution and shelf presence across the grocer’s network.

Product-Related AnnouncementsM&A TransactionsBusiness Operations and Strategy
Safety Shot Expands Retail Presence with Yerbaé Acquisition
Positive
Feb 4, 2025

On February 4, 2025, Yerbaé Brands Corp., a plant-based functional beverage company, announced a new distribution agreement with Eagle Rock Distributing Company to supply its beverages to King Soopers locations in Colorado. This strategic move aligns with Safety Shot, Inc.’s approach, which is in the process of acquiring Yerbaé, to secure significant retail presence in major supermarket chains across the United States, enhancing product availability to meet growing consumer demand for healthier beverage options.

Private Placements and FinancingM&A TransactionsBusiness Operations and Strategy
Safety Shot Ends Equity Offering, Plans Acquisition
Positive
Feb 3, 2025

On February 3, 2025, Safety Shot, Inc. announced the termination of its at-the-market equity offering program, a decision that underscores the company’s robust financial health and growth outlook. This move eliminates potential shareholder dilution and aligns with their strategy to enhance shareholder value. The company has achieved significant distribution milestones in 2024, including partnerships with major retailers such as 7-Eleven, Casey’s General Stores, and King Soopers, and is preparing to acquire Yerbaé Brands Corp., a functional beverage company. These actions are part of Safety Shot’s broader strategy to expand its market presence and drive sales growth.

Legal ProceedingsBusiness Operations and Strategy
Safety Shot Settles Litigation for Financial Growth
Positive
Jan 23, 2025

On January 23, 2025, Safety Shot, Inc. announced a settlement agreement with Bigger Capital LLC, resolving litigation and solidifying its financial foundation for growth. This settlement enhances the company’s financial flexibility, allowing it to focus on expanding its product portfolio, distribution network, and strategic partnerships in the wellness and functional beverage market, ultimately aiming to deliver value to shareholders.

Product-Related AnnouncementsBusiness Operations and Strategy
Safety Shot Expands Market Reach with Casey’s Partnership
Positive
Jan 21, 2025

On January 21, 2025, Yerbae Brands Corp. announced its expansion into over 300 Casey’s General Stores locations in the Midwest, marking a significant milestone in its growth strategy and enhancing its market presence in the functional beverage sector. This development follows Yerbae’s and Safety Shot’s strategic partnerships with 7-Eleven, where Safety Shot’s alcohol-reducing product, Sure Shot, gained significant exposure, leveraging 7-Eleven’s global reach to bolster brand visibility and consumer engagement in the wellness market.

M&A Transactions
Safety Shot to Acquire Yerbaé Brands Corp.
Positive
Jan 10, 2025

Safety Shot, Inc. is set to acquire Yerbaé Brands Corp., which has expanded its distribution through partnerships with several distributors to reach over 100 Smith’s Food & Drug locations across the western U.S. This expansion is anticipated to create synergies for Safety Shot, potentially broadening its market reach and enhancing its industry positioning through collaboration and expanded distribution opportunities.

M&A TransactionsBusiness Operations and Strategy
Safety Shot Expands with Yerbaé Brands Acquisition
Positive
Jan 8, 2025

Safety Shot, Inc. has entered into a definitive agreement to acquire Yerbaé Brands Corp., a plant-based energy beverage company with approximately $12 million in annual revenue. The acquisition is expected to create significant synergies in distribution, supply chain, and product development, positioning the combined entity for accelerated growth and market leadership in the wellness and functional beverage industry. This strategic move aims to enhance both companies’ market reach and operational efficiency while offering a diverse range of healthier beverage options to consumers.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.